# NeuRx Diaphram Pacing System (DPS) Use in Amyotrophic Lateral Sclerosis (ALS)

> **NCT03034317** · NA · WITHDRAWN · sponsor: **Synapse Biomedical**

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DEVICE:** NeuRx DPS

## Key facts

- **NCT ID:** NCT03034317
- **Lead sponsor:** Synapse Biomedical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-02-02
- **Primary completion:** 2018-02-08
- **Final completion:** 2018-02-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled
- **Last updated:** 2020-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03034317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03034317, "NeuRx Diaphram Pacing System (DPS) Use in Amyotrophic Lateral Sclerosis (ALS)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03034317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*